Letters Government undermining of NICE

NICE recommendations: why no disinvestment recommendations to offset investment decisions?

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2656 (Published 19 May 2015) Cite this as: BMJ 2015;350:h2656
  1. Dyfrig A Hughes, professor of pharmacoeconomics1,
  2. Eifiona M Wood, senior research fellow in pharmacoeconomics1,
  3. Lorna Tuersley, research officer in health technology assessment1
  1. 1Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor LL57 2PZ, UK
  1. d.a.hughes{at}bangor.ac.uk

Growing demand, alongside ever increasing costs, means that funding arrangements for new treatments are a major concern. The NHS in England and Wales is legally obliged to fund and resource interventions recommended by National Institute for Health and Care Excellence (NICE) technology appraisals, but NICE has no budgetary responsibilities over its recommendations.1

Other activities have to be displaced to fund new interventions. NICE …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe